Related Experiment Video
Updated: May 2, 2026

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Severe defects in absorptive ion transport in distal colons of mice that lack ClC-2 channels
Marcelo A Catalán1, Carlos A Flores, Mireya González-Begne
1Secretory Mechanisms and Dysfunction Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA.
Background & Aims:
The fluid secretion model predicts that intestinal obstruction disorders can be alleviated by promoting epithelial Cl(-) secretion. The adenosine 3',5'-cyclic monophosphate (cAMP)-activated anion channel CFTR mediates Cl(-)-dependent fluid secretion in the intestine. Although the role of the ClC-2 channel has not been determined in the intestine, this voltage-gated Cl(-) channel might compensate for the secretory defects observed in patients with cystic fibrosis and other chronic constipation disorders. We investigated whether mice that lack ClC-2 channels (Clcn2(-/-)) have defects in intestinal ion transport.
Methods:
Immunolocalization and immunoblot analyses were used to determine the cellular localization and the amount of ClC-2 expressed in mouse early distal colon (EDC) and late distal colon (LDC). Colon sheets from wild-type and Clcn2(-/-) littermates were mounted in Ussing chambers to determine transepithelial bioelectrical parameters and Na(+), K(+), and Cl(-) fluxes.
Results:
Expression of ClC-2 was higher in the basolateral membrane of surface cells in the EDC compared with the LDC, with little expression in crypts. Neither cAMP nor Ca(2+)-induced secretion of Cl(-) was affected in the EDC or LDC of Clcn2(-/-) mice, whereas the amiloride-sensitive short-circuit current was increased approximately 3-fold in Clcn2(-/-) EDC compared with control littermates. Conversely, electroneutral Na(+), K(+), and Cl(-) absorption was dramatically reduced in colons of Clcn2(-/-) mice.
Conclusions:
Basolateral ClC-2 channels are required for colonic electroneutral absorption of NaCl and KCl. The increase in the amiloride-sensitive short-circuit current in Clcn2(-/-) mice revealed a compensatory mechanism that is activated in the colons of mice that lack the ClC-2 channel.
Insights
Mice lacking ClC-2 channels show reduced intestinal salt absorption but activate compensatory mechanisms. This highlights ClC-2
Area of Science:
- Gastroenterology
- Ion transport physiology
- Molecular biology
Background:
- Epithelial Cl(-) secretion is key for intestinal fluid balance.
- CFTR mediates cAMP-activated intestinal Cl(-) secretion.
- ClC-2's role in intestinal ion transport remains unclear.
Purpose of the Study:
- Investigate ClC-2 channel function in intestinal ion transport.
- Determine if ClC-2 deficiency impacts intestinal fluid secretion.
- Assess ClC-2's role in colonic salt absorption.
Main Methods:
- Immunolocalization and immunoblotting for ClC-2 expression in mouse colon.
- Ussing chamber experiments to measure ion transport in wild-type and Clcn2(-/-) mice.
- Analysis of bioelectrical parameters and ion fluxes (Na(+), K(+), Cl(-)).
Main Results:
- ClC-2 is expressed in the basolateral membrane of surface cells in the early distal colon (EDC).
- ClC-2 deficiency did not affect cAMP or Ca(2+)-induced Cl(-) secretion.
- Electroneutral NaCl and KCl absorption was significantly reduced in Clcn2(-/-) colons.
- Amiloride-sensitive short-circuit current increased in Clcn2(-/-) EDC, indicating a compensatory mechanism.
Conclusions:
- Basolateral ClC-2 channels are essential for colonic electroneutral NaCl and KCl absorption.
- Mice lacking ClC-2 activate compensatory pathways in the colon.
- Findings suggest ClC-2's involvement in maintaining intestinal salt and fluid homeostasis.
More Related Videos
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inflammatory Bowel Disease II: Ulcerative Colitis

